Difference between revisions of "PARKINSONS & PARKINSONISM-PROGNOSIS"
(Imported from text file) |
(Imported from text file) |
||
| Line 4: | Line 4: | ||
<br/>2. Older age at diagnosis | <br/>2. Older age at diagnosis | ||
<br/>3. Higher baseline Hoehn & Yahr (HY) stage | <br/>3. Higher baseline Hoehn & Yahr (HY) stage | ||
<br/>4. Higher baseline Unified Parkinson's Disease Rating Scale (UPDRS) motor scores | <br/>4. Higher baseline Unified Parkinson's Disease Rating Scale (UPDRS) motor scores | ||
<br/>5. Higher bradykinesia subscores | <br/>5. Higher bradykinesia subscores | ||
Latest revision as of 02:29, 21 March 2023
SUMMARY
Factors assoc. with poor prognosis:
1. Male gender
2. Older age at diagnosis
3. Higher baseline Hoehn & Yahr (HY) stage
4. Higher baseline Unified Parkinson's Disease Rating Scale (UPDRS) motor scores
5. Higher bradykinesia subscores
6. Baseline cognitive impairment
Reference(s)
Oosterveld, L., Allen, J., Reinoso, G., Seah, S., Tay, K., Au, W. and Tan, L. (2019). Prognostic factors for early mortality in Parkinson's disease. Parkinsonism & Related Disorders, 21(3), pp.226-230.
Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. Get it on Amazon.
Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. Get it on Amazon.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].
